Science & Technology

Proviral Sequencing Driven Development of Enhanced Ipdav2 With Global Hiv-1 Group M Coverage to Support Worldwide Cure and Clinical Trials

Department of Health and Human Services — National Institutes of Health

Opportunity #: 75N93023C00017

Award Ceiling

$2.0M

Award Floor

$2.0M

Close Date

N/A

Total Funding

$2.0M

Expected Awards

Cost Sharing Required

Grants.gov ID

sbir-75N93023C00017

Description

SBIR Phase Phase II award: "PROVIRAL SEQUENCING DRIVEN DEVELOPMENT OF ENHANCED IPDAV2 WITH GLOBAL HIV-1 GROUP M COVERAGE TO SUPPORT WORLDWIDE CURE AND CLINICAL TRIALS" awarded to ACCELEVIR DIAGNOSTICS LLC in BALTIMORE, Maryland. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $2,000,000. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.

Eligible Applicants

Small businesses, Women-owned businesses

Apply on Grants.gov

Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.

View on Grants.gov

Disclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.